News & Events
Tawasol – Sept 2017 issue
Latest news from 17 organisations in the Arab region
A review of Alemtuzumab (Lemtrada)
Two recent scientific publications have reported on the long term safety and efficacy of Alemtuzumab (Lemtrada) for…
Gut bacteria and MS
New evidence of potential role of gut bacteria in MS
MS Ireland shares results of first national survey into the needs of people with MS
“My MS, My Needs” survey results help MS Ireland to improve services and advance advocacy work for…
Danish MS Society launches digital fundraising and awareness-raising campaign
The Danish MS Society is reaching out to people in Denmark through videos and social media to…
Singer with MS holds performance in Japanese school to raise awareness of MS
Keiko, a popular Japanese singer who lives with MS, performed songs to Japanese school pupils who took…
MS International Federation’s members gather in London to mark 50 years of the global MSIF movement
More than 100 staff, volunteers, and people with and affected by MS from 39 countries gathered in…
Professor Per Soelberg Sørensen wins prestigious Charcot award for research in multiple sclerosis
Prof. Sørensen, one of the world’s prominent clinical neurologists in multiple sclerosis, recognised for lifetime achievement in…
Alliance holds pivotal London meeting
A meeting of minds took place at the recent International Progressive MS Alliance event in London
Diagnosis: making it early and getting it right
Diagnosis of MS is getting faster and more efficient but new research suggests there are still ways…
Do anti-inflammatory drugs delay disability in secondary progressive MS?
A new study recently published uses ‘real-world’ data to investigate the effects of disease modifying therapies on…
Can exercise reduce disease progression in MS?
Resistance exercise increases the thickness of the brain cortex in some people with MS